We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-2.2%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$78.1B
AUM Growth
-$1.98B
(-2.5%)
Cap. Flow
-$7.02B
Cap. Flow
% of AUM
-8.99%
Top 10 Holdings %
Top 10 Hldgs %
28.7%
Holding
1,440
New
63
Increased
853
Reduced
452
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinross Gold
KGC
|
+$440M |
| 2 |
C.H. Robinson
CHRW
|
+$323M |
| 3 |
Advanced Micro Devices
AMD
|
+$322M |
| 4 |
Tyler Technologies
TYL
|
+$317M |
| 5 |
Merck
MRK
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$11.9B |
| 2 |
NVIDIA
NVDA
|
+$409M |
| 3 |
Autodesk
ADSK
|
+$261M |
| 4 |
Salesforce
CRM
|
+$258M |
| 5 |
Clorox
CLX
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.82% |
| 2 | Materials | 22.17% |
| 3 | Healthcare | 8.64% |
| 4 | Industrials | 7.37% |
| 5 | Financials | 5.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.04B
| $41K | ﹤0.01% |
1,414
+390
| +38% | +$11.3K |
|
1302
Grupo Aeroportuario del Pacifico
PAC
$13B
| $41K | ﹤0.01% |
233
+13
| +6% | +$2.34K |
|
1303
MiMedx Group
MDXG
$622M
| $40K | ﹤0.01% |
+4,120
| New | +$32.1K |
|
1304
Beyond Meat
BYND
$316M
| $39K | ﹤0.01% |
10,498
+4,280
| +69% | +$22.7K |
|
|
FOLD
1305
DELISTED
Amicus Therapeutics
FOLD
| $39K | ﹤0.01% |
4,172
+715
| +21% | +$7.43K |
|
1306
Invesco QQQ Trust
QQQ
$469B
| $39K | ﹤0.01% |
76
+40
| +111% | +$20.2K |
|
1307
ZTO Express
ZTO
$18.7B
| $39K | ﹤0.01% |
1,973
+148
| +8% | +$3.25K |
|
1308
New Fortress Energy
NFE
$95.9M
| $38K | ﹤0.01% |
2,543
+553
| +28% | +$5.73K |
|
|
OTLY
1309
Oatly Group
OTLY
$468M
| $38K | ﹤0.01% |
2,834
+1,069
| +61% | +$15.8K |
|
|
RNAM
1310
DELISTED
Avidity Biosciences
RNAM
| $38K | ﹤0.01% |
+1,315
| New | +$55K |
|
1311
Kanzhun
BZ
$7.36B
| $36K | ﹤0.01% |
2,607
-903
| -26% | -$13.3K |
|
1312
Federated Hermes
FHI
$4.85B
| $35K | ﹤0.01% |
842
-57
| -6% | -$2.3K |
|
1313
iShares 20+ Year Treasury Bond ETF
TLT
$41.4B
| $34K | ﹤0.01% |
394
+178
| +82% | +$16.4K |
|
1314
Twist Bioscience
TWST
$6.29B
| $34K | ﹤0.01% |
740
+267
| +56% | +$12.1K |
|
|
LKFT
1315
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.75B
| $32K | ﹤0.01% |
1,153
+400
| +53% | +$11.2K |
|
1316
Green Plains
GPRE
$1.17B
| $32K | ﹤0.01% |
3,344
+2,717
| +433% | +$30.6K |
|
1317
iShares 1-3 Year Treasury Bond ETF
SHY
$25B
| $32K | ﹤0.01% |
390
+187
| +92% | +$15.4K |
|
1318
VanEck High Yield Muni ETF
HYD
$4.42B
| $31K | ﹤0.01% |
605
+6
| +1% | +$314 |
|
1319
Teladoc Health
TDOC
$1.21B
| $31K | ﹤0.01% |
3,461
+659
| +24% | +$6.36K |
|
1320
VanEck Intermediate Muni ETF
ITM
$2.14B
| $30K | ﹤0.01% |
660
| – | – |
|
1321
Itaú Unibanco
ITUB
$93.6B
| $30K | ﹤0.01% |
6,898
+20
| +0.3% | +$103 |
|
1322
Coupang
CPNG
$29.5B
| $29K | ﹤0.01% |
1,300
+49
| +4% | +$1.2K |
|
1323
Phreesia
PHR
$698M
| $27K | ﹤0.01% |
1,064
+235
| +28% | +$5.02K |
|
1324
Invesco S&P 500 Equal Weight ETF
RSP
$98.1B
| $27K | ﹤0.01% |
152
+78
| +105% | +$14.1K |
|
1325
Thor Industries
THO
$4.03B
| $27K | ﹤0.01% |
287
-22
| -7% | -$2.35K |
|
Similar funds
VanEck Associates's Q4 2024 Portfolio in Review
As of Q4 2024, VanEck Associates held 1,440 positions worth $78.1B, down 2.5% from $80.1B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
VanEck Associates withdrew a net $7.02B in Q4 2024, closing 54 positions and reducing 452 holdings. Its most notable exit was Bank of New York Mellon, an estimated $9.49M position sold in full.
By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 41% a quarter earlier, followed by Materials and Healthcare.
Against the trend, VanEck Associates opened a new position in Boeing Co 6.00% Series A Preferred Stock worth $251M.
- VanEck Associates's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 4,123,397 shares worth $251M.
- VanEck Associates added most to Kinross Gold in Q4 2024, an estimated $440M increase.
- VanEck Associates's biggest Q4 2024 reduction was Lam Research, cutting an estimated $11.9B.
- VanEck Associates fully exited Bank of New York Mellon in Q4 2024, selling an estimated $9.49M.
- VanEck Associates's ten largest holdings make up 29% of its $78.1B portfolio in Q4 2024.
- VanEck Associates opened 63 new positions and closed 54 in Q4 2024.
- VanEck Associates's portfolio value fell 2.5% quarter-over-quarter to $78.1B.
Based on VanEck Associates's 13F filing for Q4 2024, filed 29 Jan 2025.